Glaukos Corporation (GKOS) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Glaukos Corporation (GKOS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

157.01

1.18%

Pre-market Jan 07, 2025, 04:38 AM EST

Glaukos Corporation Revenue Breakdown

Quarter	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Corneal Health Revenue	14.88M	12.90M	6.61M	11.20M
Corneal Health Revenue Growth	+15.29%	+95.23%	-41.00%	n/a
Glaucoma Revenue	58.36M	51.93M	24.95M	44.13M
Glaucoma Revenue Growth	+12.38%	+108.14%	-43.47%	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
International Revenue	95.31M	144.66M	170.80M
International Revenue Growth	-34.11%	-15.30%	n/a
United States Revenue	219.40M	n/a	n/a
United States Revenue Growth	n/a	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	64.00M	66.19M	61.98M	63.03M	54.25M	53.14M	53.65M	51.93M	47.15M	49.90M	43.95M	47.57M	44.47M	45.30M	41.92M	43.79M	38.95M	38.12M	50.55M	59.61M	44.44M	37.66M	34.92M	32.10M	31.63M	28.64M	27.16M	25.96M	24.14M	24.68M	21.48M	20.49M	16.85M	15.12M	12.29M	12.39M	11.24M	12.52M	7.82M
Selling, General, and Administrative Revenue Growth	-3.31%	+6.80%	-1.68%	+16.20%	+2.09%	-0.96%	+3.32%	+10.13%	-5.51%	+13.54%	-7.60%	+6.96%	-1.83%	+8.06%	-4.27%	+12.44%	+2.18%	-24.59%	-15.21%	+34.13%	+18.02%	+7.82%	+8.79%	+1.49%	+10.45%	+5.46%	+4.59%	+7.55%	-2.16%	+14.87%	+4.82%	+21.60%	+11.47%	+23.05%	-0.84%	+10.28%	-10.22%	+60.13%	n/a
Research and Development Revenue	34.75M	34.43M	30.73M	39.06M	33.30M	36.23M	35.17M	35.81M	28.87M	41.71M	26.88M	26.68M	33.85M	29.26M	21.22M	21.24M	20.30M	18.97M	24.87M	20.03M	18.78M	19.31M	13.93M	12.96M	13.20M	12.61M	10.91M	10.53M	9.80M	14.95M	8.94M	7.40M	7.81M	6.96M	7.06M	6.29M	6.17M	7.34M	5.24M
Research and Development Revenue Growth	+0.93%	+12.04%	-21.34%	+17.30%	-8.09%	+3.02%	-1.79%	+24.05%	-30.79%	+55.20%	+0.75%	-21.18%	+15.69%	+37.88%	-0.12%	+4.63%	+7.03%	-23.73%	+24.17%	+6.67%	-2.78%	+38.65%	+7.51%	-1.86%	+4.69%	+15.63%	+3.62%	+7.34%	-34.43%	+67.22%	+20.85%	-5.23%	+12.25%	-1.52%	+12.18%	+1.98%	-15.89%	+40.06%	n/a